| dbo:abstract
|
- Heather Manchin Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. Bresch has been a central figure in two controversies: a 2007 accusation of inflating her resume with an unearned MBA degree, and as the CEO of Mylan during the 2016 controversy over pricing of the company's EpiPen products. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list. Bresch is the daughter of former West Virginia Governor and current U.S. Senator Joe Manchin. (en)
- Heather Bresch (née Manchin, le 27 juin 1969) est une dirigeante d'entreprise américaine. Elle est chef de la direction de Mylan depuis 2012. Elle est la première femme à diriger une entreprise pharmaceutique Fortune 500. En 2015, elle a été classée n° 22 dans la liste des femmes les plus puissantes du magazine Fortune. Bresch est la fille de l'ancien gouverneur de la Virginie-Occidentale et actuel sénateur américain Joe Manchin. Bresch a été au centre de deux controverses : une accusation de 2007 de gonfler son curriculum vitae avec un MBA non acquis et en tant que PDG de Mylan lors de la controverse sur les prix des produits EpiPen de la société. (fr)
|
| dbo:alias
| |
| dbo:almaMater
| |
| dbo:birthDate
| |
| dbo:birthName
|
- Heather Renée Manchin (en)
|
| dbo:birthPlace
| |
| dbo:birthYear
| |
| dbo:occupation
| |
| dbo:parent
| |
| dbo:personFunction
| |
| dbo:thumbnail
| |
| dbo:title
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 30142 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
|
- West Virginia University (en)
|
| dbp:alt
|
- Bresch 2015 Headshot (en)
|
| dbp:birthDate
| |
| dbp:birthName
|
- Heather Renée Manchin (en)
|
| dbp:birthPlace
|
- Morgantown, West Virginia, U.S. (en)
|
| dbp:caption
|
- Bresch at Mylan Headquarters in 2015 (en)
|
| dbp:children
| |
| dbp:name
| |
| dbp:occupation
| |
| dbp:otherNames
| |
| dbp:parents
| |
| dbp:spouse
|
- (en)
- Douglas Kirby (en)
- Jeffrey Bresch (en)
|
| dbp:title
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Heather Manchin Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. Bresch has been a central figure in two controversies: a 2007 accusation of inflating her resume with an unearned MBA degree, and as the CEO of Mylan during the 2016 controversy over pricing of the company's EpiPen products. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list. (en)
- Heather Bresch (née Manchin, le 27 juin 1969) est une dirigeante d'entreprise américaine. Elle est chef de la direction de Mylan depuis 2012. Elle est la première femme à diriger une entreprise pharmaceutique Fortune 500. En 2015, elle a été classée n° 22 dans la liste des femmes les plus puissantes du magazine Fortune. (fr)
|
| rdfs:label
|
- Heather Bresch (en)
- Heather Bresch (it)
- Heather Bresch (fr)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:child
of | |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is rdfs:seeAlso
of | |
| is foaf:primaryTopic
of | |
